TRIL
Trillium Therapeutics Inc.
TRIL
TRIL
Delisted
TRIL was delisted on the 16th of November, 2021.
29 hedge funds and large institutions have $48.9M invested in Trillium Therapeutics Inc. in 2015 Q4 according to their latest regulatory filings, with 4 funds opening new positions, 8 increasing their positions, 8 reducing their positions, and 8 closing their positions.
New
Increased
Maintained
Reduced
Closed
more funds holding in top 10
Funds holding in top 10: →
more capital invested
Capital invested by funds: $ → $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less funds holding
Funds holding: →
50% less first-time investments, than exits
New positions opened: 4 | Existing positions closed: 8
Holders
29
Holding in Top 10
2
Calls
–
Puts
–
Top Buyers
| 1 | +$1.88M | |
| 2 | +$884K | |
| 3 | +$623K | |
| 4 |
Renaissance Technologies
New York
|
+$304K |
| 5 |
ECM
Endurant Capital Management
San Mateo,
California
|
+$158K |
Top Sellers
| 1 | -$1.22M | |
| 2 | -$847K | |
| 3 | -$445K | |
| 4 |
Alyeska Investment Group
Chicago,
Illinois
|
-$292K |
| 5 |
SFM
Sphera Funds Management
Tel Aviv,
Israel
|
-$185K |